User:Switchoffmedia/sandbox

Answers to Module 7 Questions

 * 1) Describe your media?It is a diagram of a neuron with amyloid plaques which would be found in a brain of an alzheimer's patient.
 * 2) Is it your own work? Yes
 * 3) What is the file format? jpg
 * 4) What license have you chosen?
 * 5) What category/gallery will you add it to? Alzheimers
 * 6) How will you describe the file? A diagram of a nueron surrounded by amyloid plagues, which is found in the brain of an Alzheimer's patient

{{| type      = mab | mab_type  = mab | source    =  zu/a
 * target    =


 * type      = mab  | mab_type   = 3mab | source     = zu/a | target     =beta-amyloid {{infobox clinical trial|name=|image=|image_size=|alt=|caption=|study_type=|dates=|locations=|lead_researcher=|funding=|protocol=|published_year=|published_article=}}

Practicing citations

The analysis of multiple anti-Amyloid treatments highlights the prevalence of research and trials for this specific antibody treatment

Terry highlights that Donanemab had promising results in the early stages of its trials amongst patients with Alzheimer’s.

This article is useful as it provides the necessary background information, identifying the cause of the disease being a plague of protein in the brain and how Donanemab reduced its prevalence

The authors used trial results from Eli Lilly and Company to explore the safety and tolerability of Donanemab for patients

Mintun et al. (2021) is an original article from The New England Journal of Medicine that outlines the phase 2 trial of Donanemab